Thomais Markou

1.2k total citations
28 papers, 771 citations indexed

About

Thomais Markou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Thomais Markou has authored 28 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Thomais Markou's work include Melanoma and MAPK Pathways (9 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Cardiac Fibrosis and Remodeling (5 papers). Thomais Markou is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Cardiac Fibrosis and Remodeling (5 papers). Thomais Markou collaborates with scholars based in United Kingdom, Greece and United States. Thomais Markou's co-authors include Antigone Lazou, Peter H. Sugden, Angela Clerk, Stephen J. Fuller, Timothy E. Cullingford, Alejandro Giraldo, Sampsa Pikkarainen, Margarita Hadzopoulou‐Cladaras, George Theophilidis and Christian Butter and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Hypertension.

In The Last Decade

Thomais Markou

28 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomais Markou United Kingdom 16 448 281 76 74 71 28 771
Cristián Ibarra Sweden 12 403 0.9× 198 0.7× 48 0.6× 91 1.2× 62 0.9× 21 774
Mona El Refaey United States 17 577 1.3× 205 0.7× 53 0.7× 117 1.6× 42 0.6× 29 918
Alexander Aronshtam United States 8 485 1.1× 95 0.3× 80 1.1× 51 0.7× 86 1.2× 9 755
Akiko Hayashi Japan 13 374 0.8× 126 0.4× 42 0.6× 57 0.8× 80 1.1× 38 726
Vladimir Camarena United States 18 269 0.6× 117 0.4× 88 1.2× 58 0.8× 64 0.9× 25 903
Qikuan Hu China 15 425 0.9× 111 0.4× 32 0.4× 70 0.9× 58 0.8× 27 700
Shubha Gururaja Rao United States 16 444 1.0× 93 0.3× 46 0.6× 47 0.6× 95 1.3× 25 660
Edwin Janssen Netherlands 13 509 1.1× 131 0.5× 125 1.6× 113 1.5× 56 0.8× 14 795
Shaojun Liu China 17 467 1.0× 126 0.4× 55 0.7× 72 1.0× 66 0.9× 56 941
Xutong Sun United States 22 553 1.2× 135 0.5× 33 0.4× 190 2.6× 51 0.7× 41 968

Countries citing papers authored by Thomais Markou

Since Specialization
Citations

This map shows the geographic impact of Thomais Markou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomais Markou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomais Markou more than expected).

Fields of papers citing papers by Thomais Markou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomais Markou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomais Markou. The network helps show where Thomais Markou may publish in the future.

Co-authorship network of co-authors of Thomais Markou

This figure shows the co-authorship network connecting the top 25 collaborators of Thomais Markou. A scholar is included among the top collaborators of Thomais Markou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomais Markou. Thomais Markou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinkerton, James, Silvia Preite, Antonio Piras, et al.. (2024). PI3Kγδ inhibition suppresses key disease features in a rat model of asthma. Respiratory Research. 25(1). 175–175. 2 indexed citations
2.
Alharbi, Hajed Obaid, Thomais Markou, Peter E. Glennon, et al.. (2022). Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice. Clinical Science. 136(22). 1661–1681. 5 indexed citations
3.
Pinkerton, James, Thomais Markou, Annika Borde, et al.. (2020). Profiling the impact of two JAK inhibitors in a pre-clinical model of allergic asthma. 3302–3302. 1 indexed citations
4.
Meijles, Daniel N., Georgia Zoumpoulidou, Thomais Markou, et al.. (2019). The cardiomyocyte “redox rheostat”: Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death. Journal of Molecular and Cellular Cardiology. 129. 118–129. 32 indexed citations
5.
Stangeland, Lodve, Geir Dahle, David Chambers, et al.. (2016). Myocardial function after polarizing versus depolarizing cardiac arrest with blood cardioplegia in a porcine model of cardiopulmonary bypass. European Journal of Cardio-Thoracic Surgery. 50(1). 130–139. 8 indexed citations
6.
Markou, Thomais & David Chambers. (2014). Lung injury after simulated cardiopulmonary bypass in an isolated perfused rat lung preparation: Role of mitogen-activated protein kinase/Akt signaling and the effects of theophylline. Journal of Thoracic and Cardiovascular Surgery. 148(5). 2335–2344. 9 indexed citations
7.
8.
Markou, Thomais, et al.. (2011). Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes. European Journal of Pharmacology. 667(1-3). 298–305. 20 indexed citations
9.
Markou, Thomais, et al.. (2011). Signal transduction pathways through cytoprotective, apoptotic and hypertrophic stimuli: a comparative study in adult cardiac myocytes. Cell Biochemistry and Function. 29(6). 442–451. 6 indexed citations
10.
Sugden, Peter H., Thomais Markou, Stephen J. Fuller, et al.. (2010). Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active. Cellular Signalling. 23(2). 468–477. 12 indexed citations
11.
12.
Markou, Thomais, et al.. (2009). Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radical Research. 43(9). 809–816. 39 indexed citations
13.
Cullingford, Timothy E., Thomais Markou, Stephen J. Fuller, et al.. (2008). Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes. Genome biology. 9(2). R32–R32. 39 indexed citations
14.
Markou, Thomais, et al.. (2008). Differential roles of MAPKs and MSK1 signalling pathways in the regulation of c-Jun during phenylephrine-induced cardiac myocyte hypertrophy. Molecular and Cellular Biochemistry. 322(1-2). 103–112. 15 indexed citations
15.
Markou, Thomais, Timothy E. Cullingford, Alejandro Giraldo, et al.. (2007). Glycogen synthase kinases 3α and 3β in cardiac myocytes: Regulation and consequences of their inhibition. Cellular Signalling. 20(1). 206–218. 49 indexed citations
16.
Lazou, Antigone, et al.. (2006). Dopamine mimics the cardioprotective effect of ischemic preconditioning via activation of α1- adrenoceptors in the isolated rat heart. Physiological Research. 55(1). 1–8. 16 indexed citations
17.
Markou, Thomais, et al.. (2005). Regulation of Protein Kinase C δ by Phorbol Ester, Endothelin-1, and Platelet-derived Growth Factor in Cardiac Myocytes. Journal of Biological Chemistry. 281(13). 8321–8331. 21 indexed citations
18.
Markou, Thomais, Margarita Hadzopoulou‐Cladaras, & Antigone Lazou. (2004). Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. Journal of Molecular and Cellular Cardiology. 37(5). 1001–1011. 59 indexed citations
19.
Markou, Thomais, et al.. (2002). Differential Effect of Ischemic and Pharmacological Preconditioning on PKC Isoform Translocation in Adult Rat Cardiac Myocytes. Cellular Physiology and Biochemistry. 12(5-6). 315–324. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristián Ibarra Breakdown of academic impact, for papers by Mona El Refaey Breakdown of academic impact, for papers by Alexander Aronshtam Breakdown of academic impact, for papers by Akiko Hayashi Breakdown of academic impact, for papers by Vladimir Camarena Breakdown of academic impact, for papers by Qikuan Hu Breakdown of academic impact, for papers by Shubha Gururaja Rao Breakdown of academic impact, for papers by Edwin Janssen Breakdown of academic impact, for papers by Shaojun Liu Breakdown of academic impact, for papers by Xutong Sun
Rankless by CCL
2026